16YRSBeijing Kewei Clinical Diagnostic Reagent Inc.

COMPANY OVERVIEW

Company Album3

Basic Information
In 1990, with the technology and resource advantages of 302 Hospital of the P.L.A., Beijing Kewei Clinical Diagnostic Reagents Manufacturer was established and became one of the earliest companies specialized in producing diagnostic reagents. 302 Hospital of P.L.A. is one of the largest domestic infectious hospitals with many famous clinical and diagnostic experts. It injected its advanced technology and invaluable knowledge asset into Kewei Clinical Diagnostic Reagents Manufacturer. In late 2003, by enterprise reform and assets' recombination, the former Kewei Clinical Diagnostic Reagents Manufacturer became a modern enterprise characterized by advanced management and market system-Beijing Kewei Clinical Diagnostic Reagents Co., Ltd, and with 302 Hospital set up the Cooperation Center of Research and Development for Clinical Diagnostic Reagents. At present, Kewei has obtained GMP certificate and has a 3000 square meter clean room meeting GMP requirements that laid the reliable foundation for good product quality. Kewei's products include the diagnostic kits of hepatitis B surface antigen, hepatitis B surface antibody, hepatitis B 'e' antigen, hepatitis B 'e' antibody and hepatitis B core antibody, hepatitis a virus IgM diagnostic kits, hepatitis E virus IgM diagnostic kits, RPR diagnostic kits, HBV test cassettes, HIV Ag/Ab diagnostic kits, etc. And the research and application of monoclonal antibodies against various hepatitis viruses was awarded the second prize issued by the Ministry of Science and Technology (MOST) P. R. China. Then Kewei became the first one obtained the Certificate of New Drug of EIA kit for HAV IgM and for anti-HBc. In November 2004, Kewei was awarded a certificate of high and new technological enterprise by Beijng Science and Technology Commission. In November 2005, the international forth generation HIV Ab/Ag diagnostic kit was supported by innovation fund of the year 2005 under Ministry of Science and Technology. Kewei have a professional and experienced sales team. The Domestic and International market sales volume increases rapidly each year, is the superior positions in blood screening tests for infectious diseases in China. Our marketing efforts extend to the fields of clinical testing, disease control and prevention, blood screening etc.
  • 5 Transactions
    10,000+
  • Response Time
    ≤2h
  • Response rate
    97.14%
Business type
Manufacturer, Trading Company
Country / Region
Bejing, China
Main ProductsTotal employees
101 - 200 People
Total Annual Revenue
US$1 Million - US$2.5 Million
Year established
1990
Certifications
-
Product Certifications
-
Patents
-
Trademarks(1)
Main Markets

PRODUCT CAPACITY

Factory Information

Factory Size
1,000-3,000 square meters
Factory Country/Region
19,Guchengxijie, Shijingshan District, Beijing city, China
No. of Production Lines
3
Contract Manufacturing
OEM Service Offered, Design Service Offered, Buyer Label Offered
Annual Output Value
US$5 Million - US$10 Million

Annual Production Capacity

Product Name
units Produced
highestEver
unit Type
Verified
diagnostic test kits
20000000
30000000
Piece/Pieces
Verified